Replies to post #198600 on Enzolytics Inc (ENZC)

[Valuator2]

Have you been following this case, and if so, what is your assessment of it? I haven't followed it.
Have you looked into the history of the plaintiffs? One was disbarred and has a history in lawsuits on behalf of the other plaintiff's family. Comments by judges in some of those suits are quite interesting. The other plaintiff's cases against ENZC have been dismissed in several venues. JMHO. How about this one?
https://www.courtlistener.com/docket/67807413/mergenthaler-v-zimbler/

[docsetc]

CCC controls and owns the IP's that were previously assigned to BGEN. If they regain control of ENZC, they can use or even reassign those IP's back to ENZC. Only takes signed letters from Chandra and Cotropia. Currently those IP's are assigned to Adnexus and MABS-Tech, the shell companies meant to keep them protected, (and ready to move forward with, if necessary), and they regain the ENZC shareholders, which is a main component of what they are trying to do.

If they do regain control of ENZC, they better quite playing with the devils. Charles has to stay busy on too many attacking legal matters, even if they are just junk complaints and lawsuits. Get one or both of their big pharma suitors signed, and get moving along.

What Brad found, don't have it this minute, was one of the old Sagaliam PR's where it was clearly noted that the SPAC deal was "dedicated to maintaining the listing on NASDAQ and satisfying NASDAQ requirements for both listing and shareholder transactions." I'll see if he can email that over.
Even if it wasn't true, if could be binding in court that this SPAC is completely dissolved by NASDAQ delisting, just like Timing said. SAGA is gone, Harry's probably working on the illusion of it being alive, holding onto the shareholders as long as he can.

GLTY!

[docsetc]

CCC controls and owns the IP's that were previously assigned to BGEN. If they regain control of ENZC, they can use or even reassign those IP's back to ENZC. Only takes signed letters from Chandra and Cotropia. Currently those IP's are assigned to Adnexus and MABS-Tech, the shell companies meant to keep them protected, (and ready to move forward with, if necessary), and if they regain the ENZC shareholders, which is a main component of what they are trying to do, things can get better, fast.

If they do regain control of ENZC, they better quite playing with the devils. Charles has to stay busy on too many attacking legal matters, even if they are just junk complaints and lawsuits. Get one or both of their big pharma suitors signed, and get moving along.

What Brad found, don't have it this minute, was one of the old Sagaliam PR's where it was clearly noted that the SPAC deal was "dedicated to maintaining the listing on NASDAQ and satisfying NASDAQ requirements for both listing and shareholder transactions." I'll see if he can email that over.
Even if it wasn't true, if could be binding in court that this SPAC is completely dissolved by NASDAQ delisting, just like Timing said. SAGA is gone, Harry's probably working on the illusion of it being alive, holding onto the shareholders as long as he can.

GLTY!